Cover Image

Structural and molecular insights from dual inhibitors of EGFR and VEGFR2 as a strategy to improve the efficacy of cancer therapy

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Krisyanti Budipramana, Frangky Sangande
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Chemical Biology & Drug Design
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Structural modification of 2‐phenylquinoline‐4‐carboxylic acid containing SIRT3 inhibitors for the cancer differentiation therapy
by: Yanmei Du, et al.
Published: (2024)

EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue
by: Jiayi Shen, et al.
Published: (2024)

Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐targeting agents
by: Mohammad Imtiyaz Ali, et al.
Published: (2024)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
by: Kalyani R. Thombre, et al.
Published: (2026)

Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease
by: Efe Doğukan Dincel, et al.
Published: (2024)

Development of Quinoline‐Isoxazole Hybrids With Selective Cytotoxicity and EGFR Kinase Binding: In Vitro and In Silico Approaches
by: Yasemin Zeynep Şahin, et al.
Published: (2025)

Diethoxyphosphoryloxy‐oleanolic acid is a nanomolar‐inhibitor of butyrylcholinesterase
by: Anastasiya V. Petrova, et al.
Published: (2024)

Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays
by: Faten Farouk, et al.
Published: (2024)

In vitro modulation the Notch pathway by piperine: A therapeutic strategy for docetaxel‐resistant and non‐resistant prostate cancer
by: Rui‐tao Wang, et al.
Published: (2024)

Discovering novel derivatives of STAT3 and HDAC inhibitors with anti‐tumor activity
by: Yu Yang, et al.
Published: (2024)

Advancements in inhibitors of crucial enzymes in the cysteine biosynthetic pathway: Serine acetyltransferase and O‐acetylserine sulfhydrylase
by: Yinhui Qin, et al.
Published: (2024)

Integrative analysis of ex vivo studies and microarray reveals the novel inhibitor effects of trehalose on the pathogenesis of pterygium
by: Yasin Durkal, et al.
Published: (2024)

Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups
by: Bo Han, et al.
Published: (2024)

A hybrid evaluation of the intestinal absorption performance of compounds from molecular structure
by: Mengke Sheng, et al.
Published: (2024)

Discovery of novel chromone and acrylate‐based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity
by: Prashant S. Auti, et al.
Published: (2024)

Systematic profiling of Taxol resistance and sensitivity to tubulin missence mutations at molecular and cellular levels
by: Lihua Zhou, et al.
Published: (2024)

Role of Qufeng Tongqiao Prescription in the protection of cerebral ischemia and associated molecular network mechanism
by: Xue Bai, et al.
Published: (2024)

Novel carbamodithioate regulates cellular hypoxia through chemical activation of prolyl hydroxylase‐2 for breast cancer chemoprevention
by: Shubham Rastogi, et al.
Published: (2024)

Substrate‐based synthetic strategies and biological activities of 1,3,4‐oxadiazole: A review
by: Upasana Sharma, et al.
Published: (2024)

Stachydrine represses the proliferation and enhances cell cycle arrest and apoptosis of breast cancer cells via PLA2G2A/DCN axis
by: Zhen Zhai, et al.
Published: (2024)

Mechanistic insights into targeting caspase‐3 activation and alveolar macrophage pyroptosis by Ephedra and bitter almond compounds for treating pediatric pneumonia via network pharmacology and bioinformatics
by: Lei Wang, et al.
Published: (2024)

Sinigrin improves cerebral ischaemia‐reperfusion injury by inhibiting the TLR4 pathway‐mediated oxidative stress
by: Shenglong Guo, et al.
Published: (2024)

Corrigendum to ‘Sinigrin improves cerebral ischaemia‐reperfusion injury by inhibiting the TLR4 pathway‐mediated oxidative stress’
Published: (2024)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
by: Jiayi Shen, et al.
Published: (2024)

Baicalin inhibits monosodium urate crystal‐induced pyroptosis in renal tubular epithelial cell line through Panx‐1/P2X7 pathways: Molecular docking, molecular dynamics, and in vitro experiments
by: Wanting Fu, et al.
Published: (2024)

Triptolide restrains the growth, invasion, stemness, and glycolysis of non‐small cell lung cancer cells by PFKFB2‐mediated PI3K/AKT pathway
by: Jiankun Ren, et al.
Published: (2024)

Curcumin activates the JNK signaling pathway to promote ferroptosis in colon cancer cells
by: Wei Xin, et al.
Published: (2024)

MW‐19, a dihydropyrazole derivative, induces human triple‐negative breast cancer cell apoptosis by targeting apoptosis‐related pathways
by: Nanting Zou, et al.
Published: (2024)

Integrated bioinformatics analysis reveals the bidirectional effects of TSPAN6 for cisplatin resistance in lung cancer
by: Zhihong Fang, et al.
Published: (2024)

Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression
by: Yunhao Jia, et al.
Published: (2024)

An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐induced skin inflammation by targeting the CYP19A1
by: Xiaoyan Lu, et al.
Published: (2024)

Investigating potential mechanisms of vitamin D against thyroid cancer via network pharmacology and experimental validation
by: Bin Liu, et al.
Published: (2024)

Curcumin affects apoptosis of colorectal cancer cells through ATF6‐mediated endoplasmic reticulum stress
by: Wei Xu, et al.
Published: (2024)

From Synthesis to Efficacy: Synthesis, Structural Analysis, and Antiviral Activity of 5‐(Trifluoromethoxy)‐ 1 H ‐indole‐2,3‐dione 3‐Thiosemicarbazones
by: Özge Soylu‐Eter, et al.
Published: (2026)

Hydromorphone hydrochloride preconditioning combined with postconditioning attenuates myocardial ischemia/reperfusion injury in rats by improving mitochondrial function and activating the PI3K/Akt signaling pathway
by: Liuji Qiu, et al.
Published: (2024)

Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D‐Cys6‐LHRH vedotin, against ovarian cancer cell lines
by: Subramanyam Vankadara, et al.
Published: (2024)

Quercetin inhibits breast cancer cell proliferation and survival by targeting Akt/mTOR/PTEN signaling pathway
by: Ji Jiang, et al.
Published: (2024)

Thymoquinone potentiates anti‐cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress
by: Mohsen Karami Fath, et al.
Published: (2024)

Peimenine unleashes therapeutic promise in urothelial bladder cancer: inhibition of proliferation, induction of cell death and modulation of key pathways
by: Zhao Yang, et al.
Published: (2024)

IGF2BP3 loss inhibits cell progression by upregulating has_circRNA_103820, and hsa_circRNA_103820‐encoded peptide inhibits cell progression by inactivating the AKT pathway in lung cancer
by: Jinrong Zhou, et al.
Published: (2024)